 Most clinical trials involving NMDA receptor antagonists have failed due to unwanted side effects of the drugs; since the receptors also play an important role in normal glutamatergic neurotransmission, blocking them causes side-effects.These results have not yet been reproduced in humans, however.Mild NMDA receptor antagonists like amitriptyline have been found to be helpful in benzodiazepine withdrawal.